Article Text

PDF
Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer
  1. Songül Tezcan1,
  2. Fikret Vehbi İzzettin1,
  3. Mesut Sancar1,
  4. Nazım Serdar Turhal2,
  5. Perran Fulden Yumuk3
  1. 1Department of Clinical Pharmacy, Faculty of Pharmacy, The University of Marmara, Istanbul, Turkey
  2. 2Department of Internal Medicine, Division of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey
  3. 3Department of Internal Medicine, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
  1. Correspondence to Songül Tezcan, Tibbiye Cad. No:49,Haydarpasa/Istanbul, Turkey; songulbutur{at}hotmail.com

Abstract

Objective To determine and evaluate the pharmaceutical care needs and quality of life of patients with colorectal cancer.

Methods 36 Patients with colorectal cancer eligible for chemotherapy after surgery were included in the study. The patients were followed up during 3 courses of chemotherapy and individual pharmaceutical care plans were developed. The quality of life of patients was evaluated before and after the third course of chemotherapy.

Results The incidence of drug-related problems (DRPs) in chemotherapy-treated patients was reduced in the 3rd course as compared with 1st course (63.9% vs 75%, respectively; n=36; p>0.05). The clinical oncology pharmacist gave 147 recommendations to patients, which were followed in 98% (n=144) of cases. 91.7% (n=132) of the recommendations of clinical oncology pharmacists solved the drug-related problems; however, the remaining 8.3% (n=12) did not solve the problems and the patients were referred to a doctor for further investigations. The symptom-related quality of life of patients related to anaemia, diarrhoea and neurotoxicity was reduced after the third course of chemotherapy (p<0.05).

Conclusions The pharmaceutical care provided by the clinical oncology pharmacist has an important role in the identification and resolution of DRPs. Evaluation of symptom-related quality of life is important for the monitoring of patients receiving chemotherapy.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.